Welcome to our dedicated page for Rhino Biotech news (Ticker: RBRXF), a resource for investors and traders seeking the latest updates and insights on Rhino Biotech stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Rhino Biotech's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Rhino Biotech's position in the market.
Rhino Biotech Limited (OTCPINK:RBRXF) announced its participation in the Planet MicroCap Showcase on May 4, 2022, at 2:30 p.m. PDT. Chief Strategy Officer Justin DeAngelis will present and engage with investors. Access the live presentation here. Rhino Biotech specializes in producing active ingredients from natural sources for health applications. Recent achievements include operating a fully automated lab and generating first revenues from seed sales. For more details, visit rhinobiotech.com.
Rhino Biotech Limited (OTC:RBRXF) has announced its entry into the biotech sector through strategic acquisitions. The company acquired Artesian Valley Farms, LLC for $14.5 million in shares and $3.4 million in financing, and JRD Ventures, LLC for $3.1 million in shares. Additionally, Rhino Biotech, Inc. was acquired for $10 million in shares. These acquisitions aim to bolster Rhino's focus on plant-based health products, specifically in the cannabis genetics field, allowing the company to leverage proprietary strains developed for medical research.
Rhino Biotech Limited (OTC:RBRXF), formerly Eurasia Energy, is pivoting to the biotech sector, focusing on plant and fungi-derived nutraceuticals and biopharmaceuticals. The company aims to pioneer in these fields by exploring potential acquisitions and has appointed a new board to spearhead growth. Recent corporate changes include the resignation of key directors and the election of new members, alongside a name change and amendments to authorized share structure. The company has engaged Paulson Investment Company as financial advisor for future capital raises.
FAQ
What is the current stock price of Rhino Biotech (RBRXF)?
What is the market cap of Rhino Biotech (RBRXF)?
